These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12693146)

  • 21. [New nonsteroidal antiinflammatory drugs in rheumatoid arthritis].
    Berenbaum F
    Ann Med Interne (Paris); 2002 Feb; 153(1):25-33. PubMed ID: 11994687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
    Wooltorton E
    CMAJ; 2002 Jun; 166(13):1692-3. PubMed ID: 12126328
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 24. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
    Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
    MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
    [No Abstract]   [Full Text] [Related]  

  • 26. [A critical evaluation of side effect data on COX-2 inhibitors].
    Pomp E
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):476-80. PubMed ID: 11961974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastroduodenal lesions in children with juvenile rheumatoid arthritis.
    Len C; Hilario MO; Kawakami E; Terreri MT; Becker DJ; Goldenberg J; Fagundes Neto U
    Hepatogastroenterology; 1999; 46(26):991-6. PubMed ID: 10370653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The selective Cox-2 inhibition by rofecoxib reduces risk of severe gastrointestinal complications of anti-inflammatory therapy by more than 50%].
    Kellner H
    Z Gastroenterol; 2001 May; 39(5):443-5. PubMed ID: 11413920
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?
    Chiolero A; Maillard MP; Burnier M
    Expert Opin Drug Saf; 2002 May; 1(1):45-52. PubMed ID: 12904159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [NSAID-gastropathy and Helicobacter pylori: more questions than answers].
    Shirinskaia NV; Akhmedov VA
    Eksp Klin Gastroenterol; 2010; (9):116-20. PubMed ID: 21427936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori and peptic-ulcer disease.
    Caselli M; Alvisi V
    Lancet; 2002 Jun; 359(9321):1943-4; author reply 1944. PubMed ID: 12057573
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection.
    Pérez-Aisa MA; Del Pino D; Siles M; Lanas A
    Aliment Pharmacol Ther; 2005 Jan; 21(1):65-72. PubMed ID: 15644047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coxib spares the stomach. This is true also for patients with preventive aspirin administration].
    MMW Fortschr Med; 2002 May; 144(20):62. PubMed ID: 12119888
    [No Abstract]   [Full Text] [Related]  

  • 35. [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle].
    Lesur G
    Gastroenterol Clin Biol; 2001; 25(6-7):725-6. PubMed ID: 11688500
    [No Abstract]   [Full Text] [Related]  

  • 36. Helicobacter pylori infection in rheumatoid arthritis: effect of drugs on prevalence and correlation with gastroduodenal lesions.
    Kelly C; Saravanan V
    Rheumatology (Oxford); 2003 Feb; 42(2):388; author reply 388. PubMed ID: 12595646
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-steroidal anti-inflammatory drug-induced gastroduodenal toxicity and Helicobacter pylori.
    Wardi J; Shirin H
    Isr Med Assoc J; 2003 Mar; 5(3):195-7. PubMed ID: 12725142
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adverse effects of NSAIDs in treatment of rheumatoid arthritis].
    Kato M; Takeda H; Asaka M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():560-5. PubMed ID: 15799418
    [No Abstract]   [Full Text] [Related]  

  • 39. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V; Hutchins B
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: are idiopathic (non-NSAID, non-Helicobacter pylori) ulcers really increasing?
    Calvet X; Gisbert JP
    Aliment Pharmacol Ther; 2012 Sep; 36(6):600-1; author reply 601-2. PubMed ID: 22913848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.